Has Scott Burlison, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,518 in general payments to Scott Burlison, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Burlison, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Burlison, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Burlison, MD

Pain Medicine · Tyler, TXNPI 1932303534

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,920 of the $2,518 with a category attached, or 76.3%. 11 manufacturers reported payments, led by Nevro Corp. at 55.3% of the total. Reporting peaked in 2024 at $861 and has fallen 90.7% since, to $80 in 2025. That places this record below the midpoint for pain medicine clinicians in TX, where the typical reported total is $3,132.

$2,518in general payments, 2019–2025

Across 36 payments — averaging $69.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$1K
Abbott$291
Medtronic$207
Stimwave Technologies Incorporated$172
Biotronik NRO, Inc.$142
Stryker$133
plus $180 from 5 others

$9,280in research payments, 2019–2025

Across 10 payments — averaging $928.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Nevro Corp.$9K

What the payments were for

Travel & lodging$56222%
Food & beverage$1,92076%
Education$361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	11	$1,393
Abbott	8	$291
Medtronic	3	$207
Stimwave Technologies Incorporated	3	$172
Biotronik NRO, Inc.	1	$142
Stryker	2	$133
Nalu Medical, Inc.	3	$69
Boston Scientific	2	$38
Amgen	1	$25
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$25
Saluda Medical Americas, Inc.	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Senza Spinal Cord Stimulation System$700
Senza$253
INTELLIS ADAPTIVESTIM$159
Prospera$142
StimQ Peripheral Nerve StimulatorSystem$127
SCS FreedonSpinal Cord Stimulator$127
Omnia$111
MAKO$105
Proclaim Family of SCS IPGs$100

How this compares

$2,518 in reported general payments places this provider in the 40th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$456,338

Medicare patients

849

Services billed

6,766

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	1,867	$50,943
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	146	$3,904
Tramadol Hcl	266	$3,288
Pregabalin	163	$3,010
Gabapentin	238	$3,007
Acetaminophen-CodeineAcetaminophen With Codeine	86	$1,779
Tizanidine Hcl	128	$1,355
Cyclobenzaprine Hcl	76	$947
Lidocaine	16	$624
Methocarbamol	40	$557
Celecoxib	17	$454
Amitriptyline Hcl	27	$298
Ibuprofen	27	$288
Meloxicam	64	$265
Diclofenac Sodium	16	$260

Paid to pharmacies, not to this prescriber.

Other pain medicine in Tyler

Aaron CalodneyTyler$296K
Melissa MurphyGrapevine$653K
Shiraz YazdaniLubbock$514K
Candice BurnetteSugar Land$265K
Ashley Bailey-ClassenFort Worth$244K
Grant ChenHouston$175K
Gunjan PatelHouston$166K
Anthony BergRockwall$165K
Puneet SayalCorpus Christi$153K
Eduardo GarciaWebster$147K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →